Form 8-K - Current report:
SEC Accession No. 0001437749-22-007112
Filing Date
2022-03-25
Accepted
2022-03-24 17:44:41
Documents
21
Period of Report
2022-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20220324_8k.htm   iXBRL 8-K 46849
2 EXHIBIT 1.1 ex_350578.htm EX-1.1 390459
3 EXHIBIT 4.1 ex_350579.htm EX-4.1 94626
4 EXHIBIT 4.2 ex_350580.htm EX-4.2 94632
5 EXHIBIT 4.3 ex_350581.htm EX-4.3 112878
6 EXHIBIT 5.1 ex_350583.htm EX-5.1 24022
7 EXHIBIT 99.1 ex_350585.htm EX-99.1 16333
8 EXHIBIT 99.2 ex_350591.htm EX-99.2 15498
13 logo01.jpg GRAPHIC 9028
  Complete submission text file 0001437749-22-007112.txt   1118999

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA stab-20220322.xsd EX-101.SCH 3601
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stab-20220322_def.xml EX-101.DEF 11532
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE stab-20220322_lab.xml EX-101.LAB 15414
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stab-20220322_pre.xml EX-101.PRE 11688
15 EXTRACTED XBRL INSTANCE DOCUMENT cbli20220324_8k_htm.xml XML 2571
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 22767693
SIC: 2834 Pharmaceutical Preparations